Search results
Results from the WOW.Com Content Network
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB.. The medical standard for active TB is a short course treatment involving a combination of isoniazid, rifampicin (also known as Rifampin), pyrazinamide, and ethambutol for the first two months.
The treatment takes three to nine months depending on the medications used. [ 75 ] [ 140 ] [ 143 ] [ 142 ] People with latent infections are treated to prevent them from progressing to active TB disease later in life.
(S,S)-(+)-Ethambutol is powerful and selective antitubercular drug.It is a typical example of an old drug that was introduced for clinical use in its unichiral form. . Ethambutol contains two constitutionally symmetrical chiral centers in its structure and exists in three stereoisomeric forms, the enantiomeric pair (+)-(S,S)- and (−)-(R,R)-ethambutol, along with the achiral stereoisomer called m
The Bacillus Calmette–Guérin (BCG) vaccine is a vaccine primarily used against tuberculosis (TB). [9] It is named after its inventors Albert Calmette and Camille Guérin. [10] [11] In countries where tuberculosis or leprosy is common, one dose is recommended in healthy babies as soon after birth as possible. [9]
Duration of symptoms can vary, and ranges between weeks to months following initial onset. [1] Unilateral lymph node involvement accounts for the majority of cases, and involvement of the cervical lymph nodes is the most common. [1] In addition to swollen lymph nodes, the person may experience mild fevers, decreased appetite, or weight loss. [5]
Pyrazinamide is used in the first 2 months of treatment to reduce the duration of treatment required. [7] Regimens not containing pyrazinamide must be taken for 9 months or more. Pyrazinamide is a potent antiuricosuric drug [8] and consequently has an off-label use in the diagnosis of causes of hypouricemia and hyperuricosuria. [9] It acts on ...
It is in the nitroimidazole class of medications. [5] Delamanid was approved for medical use in 2014 in Europe, Japan, and South Korea. [6] It is on the World Health Organization's List of Essential Medicines. [7] As of 2016 the Stop TB Partnership had an agreement to get the medication for US$1,700 per six month for use in more than 100 ...
Ethionamide is in the thioamides family of medications. It is believed to work by interfering with the use of mycolic acid. [5] Ethionamide was discovered in 1956 and approved for medical use in the United States in 1965. [5] [2] It is on the World Health Organization's List of Essential Medicines. [6]